Издательство РАДИОТЕХНИКА

A.V. Smirnov, G.L. Snigur, M.V. Schmidt, N.G. Panshin, O.Y. Evsiukov, V.A. Tolokolnikov, T.F. Smirnova, D.V. Bulanov, A.A. Spasov, L.I. Bugaeva, M.V. Kharitonova, A.A. Zheltova, T.M. Bundikova

Vegf signaling pathway components and matrix metalloproteinases - in tumors of patients with ovarian neoplasms

D.N. Kushlinsky - Physician cancers, Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia
E.S. Gershtein - Dr.Sc. (Biol.), Professor, Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia. E-mail: esgershtein@gmail.com
I.V. Tereshkina - Ph.D. (Med.), Moscow State University of Medicine and Dentistry named A.I. Evdokimov
V.D. Ermilova - Ph.D. (Med.), Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
K.P. Laktionov - Dr.Sc. (Med.), Professor, Russian Cancer Research Center of N.N. Blokhin Russian Academy of Medical Sciences, Moscow, Russia
L.V. Adamyan - Dr.Sc. (Med.), Professor, Academician RAS, Research Center for Obstetrics, Gynecology and Perinatology, Moscow, Russia

MicroRNA - new promising tumor biological markers and targets for chemothe-rapy. Part 2. Clinical studies of microRNA in oncologic diseases

A.N. Shirshova - Researcher, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian Branchof the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk M.A. Smetanina - Ph.D.(Biol.), Researcher, Laboratory of Pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian Branchof the Russian Academy of Sciences (ICBFM SB RAS), Novosibirsk V.N. Aushev - Ph.D.(Med.), Senior Researcher, Laboratory of Oncogenes Regulation, Carcinogenesis Institute, N.N.Blokhin Russian Cancer Research Center, Moscow M.L. Filipenko - Ph.D.(Biol.), Head of the laboratory of pharmacogenomics, Institute of Chemical Biology and Fundamental Medicine Siberian branchof the Russian Academy of Sciences, Novosibirsk N.E. Kushlinskii - Dr.Sc. (Med.), Professor, Head of the Clinical Biochemistry Laboratory, N.N. Blokhin Russian Cancer Research Center, Moscow

Insulin-like growth factors and serum igf binding proteins in ovarian tumor patients

E.S. Gershtein - Dr.Sc. (Biol.), Professor, N.N. Blokhin Russian Cancer Research Center (Moscow) E.R. Isaeva - Post-graduate Student, N.N. Blokhin Russian Cancer Research Center (Moscow) D.N. Kushlinsky - Surgeon oncogynecologist, Scientific Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov (Moscow) E.A. Korotkova - Ph.D. (Biol.), Senior Research Scientist, N.N. Blokhin Russian Cancer Research Center (Moscow) V.D. Ermilova - Ph.D. (Med.), Leading Research Scientist, anatomical pathologist, N.N. Blokhin Russian Cancer Research Center (Moscow) K.P. Laktionov - Dr.Sc. (Med.), Professor, N.N. Blokhin Russian Cancer Research Center (Moscow) L.V. Adamyan - Dr.Sc. (Med.), Professor, Scientific Center for Obstetrics, Gynecology and Perinatology named after V.I. Kulakov (Moscow)

Surgical treatment of ovarian cancer (review)

N.A. Ognerubov – Dr.Sc.(Med.), Professor, Head Department of Oncology,

G.R. Derzhavin Tambov State Medical University

D.N. Kushlinsky – Ph.D. (Med.), Department of Radiation and Combined Methods of Treatment of Gynecological Diseases, A.F. Tsyb Medical Radiological Scientific Center – Branch of the Federal

State Budgetary Institution «National Medical Research Center of Radiology» of the Ministry of Health of Russia (Obninsk)

A.S. Shevchuk – Ph.D. (Med.), Head Oncology Department of Surgical Methods of Treatment (Oncogynecology) Federal State Budgetary Institution «N.N. Blokhin National Medical Research Center for Oncology» of the Ministry of Health of Russia (Moscow)

Clinical implication of the programmed cell death-1 protein PD-1 and its ligand PD-L1 in ovarian cancer (review)

E.S. Gershtein – Dr. Sc. (Biol.), Professor, Leading Research Scientist, Clinical Biochemistry Laboratory,

N.N. Blokhin National Medical Research Center of Oncology (Moscow)

D.N. Kushlinsky – Ph.D. (Med.), Senior Research Scientist, Department of Radiation and Combined Treatment of Gynecological Diseases, Medical Radiological Scientific Center n.a. A.F. Tsyba – Branch of the Federal State

Budgetary Institution «National Medical Center of Radiology» of the Ministry of Health of Russian Federation (Moscow)

I.V. Tereshkina – Ph.D. (Med.), Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

D.O. Utkin – Surgeon, Department of Oncogynecology, Moscow City Oncological Hospital № 62» (Moscow)

N.E. Kushlinskii – Dr.Sc. (Med.), Professor, Academician of RAS, Heard of Clinical Biochemistry Laboratory, N.N. Blokhin National Medical Research Center of Oncology (Moscow)

Ovarian cancer: role and location of radiotherapy

N.A. Ognerubov1, D.N. Kushlinskiy2

1 G.R. Derzhavin Tambov State Medical University of the Ministry of Science and Higher Education of the Russian Federation (Tambov, Russia)

2 A.F. Tsyb MRRC – Branch of the Federal State Budgetary Institution «National Medical Research Center of Radiology» of the Ministry of Health of Russia (Moscow, Russia)

Analysis of methylation levels of miRNA genes in tumors and metastases, taking into account the concentrations of VEGF in the blood plasma of patients with ovarian cancer

V.I. Loginov1, I.V. Tereshkina2, D.N. Kushlinsky3, A.A. Alferov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, E.A. Braga8, O.V. Kovaleva9, N.E. Kushlinskii10

1,4,8,10 Research Institute of General Pathology and Pathophysiology (Moscow, Russia)

2 A.I. Evdokimov Moscow State University of Medicine and Dentistry of the Ministry of Health of Russia
(Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health of the Khabarovsk Territory (Khabarovsk, Russia)

4–7,9,10 N.N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of Russia (Moscow, Russia)

Ovarian cancer and B7-H3 and B7-H4 ligands

O.V. Kovaleva1, D.N. Kushlinskiy2, A.N. Gratchev3, E.P. Shapiro4, A.S. Mochalova5, N.Yu. Sokolov6, N.E. Kushlinskii7

1,3,5–7 N.N. Blokhin National Medical Research Center for Oncology
of the Ministry of Health of the Russian Federation (Moscow, Russia)

2,4 Clinical Center of Oncology (Khabarovsk, Russia)

miRNAs in the regulation of the PD-1/PD-L1 immune checkpoint in ovarian cancer

D.O. Utkin1, V.I. Loginov2, D.N. Kushlinsky3, N.Yu. Sokolov4, A.I. Koltunova5, N.A. Arzhanukhina6, D.V. Rogozhin7, J.G. Pajanidi8, E.A. Braga9

1,4–8 Blokhin National Medical Research Center of Oncology,
Ministry of Health of the Russian Federation (Moscow, Russia)

1 Moscow City Oncology Hospital №62 (Moscow, Russia)

2,9 Institute of General Pathology and Pathophysiology (Moscow, Russia)

3 Institute for advanced training of healthcare professionals of the Ministry of Health
of the Khabarovsk Territory (Khabarovsk, Russia)